Bruker (BRKRP) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.70% |
| Dec 31, 2025 | 16.84% |
| Sep 30, 2025 | 15.97% |
| Jun 30, 2025 | 20.46% |
| Mar 31, 2025 | 27.08% |
| Dec 31, 2024 | 23.59% |
| Sep 30, 2024 | 10.92% |
| Jun 30, 2024 | 7.99% |
| Mar 31, 2024 | -3.88% |
| Dec 31, 2023 | -8.94% |
| Sep 30, 2023 | -5.77% |
| Jun 30, 2023 | -17.62% |
| Mar 31, 2023 | -16.32% |
| Dec 31, 2022 | -8.70% |
| Sep 30, 2022 | -8.06% |
| Jun 30, 2022 | -10.37% |
| Mar 31, 2022 | -38.01% |
| Dec 31, 2021 | -18.80% |
| Sep 30, 2021 | -8.58% |
| Jun 30, 2021 | -30.81% |
| Mar 31, 2021 | -12.12% |
| Dec 31, 2020 | -29.33% |
| Sep 30, 2020 | -2.94% |
| Jun 30, 2020 | 12.97% |
| Mar 31, 2020 | -11.61% |
| Dec 31, 2019 | -6.19% |
| Sep 30, 2019 | 7.68% |
| Jun 30, 2019 | 9.19% |
| Mar 31, 2019 | 8.32% |
| Dec 31, 2018 | 6.30% |
| Sep 30, 2018 | 2.90% |
| Jun 30, 2018 | -0.23% |
| Mar 31, 2018 | -0.68% |
| Dec 31, 2017 | -6.99% |
| Sep 30, 2017 | -11.99% |
| Jun 30, 2017 | -12.77% |
| Mar 31, 2017 | 4.44% |
| Dec 31, 2016 | -15.26% |
| Sep 30, 2016 | -17.72% |
| Jun 30, 2016 | -1.66% |
| Mar 31, 2016 | -16.82% |
| Dec 31, 2015 | 2.70% |
| Sep 30, 2015 | -23.07% |
| Jun 30, 2015 | -21.23% |
| Mar 31, 2015 | -19.09% |
| Dec 31, 2014 | -19.06% |